Jordana Joy, Associate Editor

Sheila Setork, OD, gives insight and advice on how to optimize daily disposables in order to improve retention rates and introduce more patients to contact lenses.

Jade Coats, OD, FAAO, gives her insight on what makes EyeCon valuable for eye care providers.

Catch up on the top stories in optometry during the week of August 18-August 22.

The DOT lens has now been launched across Asia-Pacific, Europe, and North America, with an estimated 500,000 fitted with DOT lenses in 2025 alone.

The acquisition focuses on LayerBio's OcuRing-K technology, with plans to initiate the next clinical trial.

Researchers found that patients with primary open-angle glaucoma have less agmatine and thiamine in the aqueous humor than patients without glaucoma.

Researchers used adaptive optics scanning light ophthalmoscopy (AOSLO) to study retinas in mice with photoreceptor damage, specifically photoreceptor laser injury.

Now, PECAA Max members will have access to ABB’s independent lab network and comprehensive portfolio of premium and proprietary lenses.

The study included the screening of 9857 drivers in 8 Indian states at automative shops and transit hubs.

Specifically, the study found that the muscle that controls eyelid movement, or the orbicularis oculi, “contracts in complex patterns that vary by action and move the eyelid in more than just a simple up-and-down motion."

The campaign provides Generation Z insights, comprehensive practice resources, and PRECISION contact lens portfolio rebates.

Catch up on the top stories in optometry during the week of August 11-August 15.

Dr Allen, OD, FAAO, Dipl ABO, plans to talk all things ocular surface for optometrists and ophthalmologists alike.

The committee will work to help the organization increase awareness and early identification of diabetes-related eye diseases, improve access to eye care treatment, policy development, research, and surveillance.

The study explored the use of DMSt, used in OptiLIFT, in enhancing eyelid muscle function, improving blink dynamics, and consequently alleviating dry eye symptoms.

Data used in the post hoc analysis were from 56 parameters from 4 testing modalities obtained in a multicenter US trial (NCT03197870).

The net plastic neutral contact lens initiative is part of CooperVision’s partnership with Plastic Bank.

Rachelle Lin, OD, MS, FAAO, has refined her passions for academia, teaching, low vision practice, and advocacy work to build out a well-rounded career.

Diagnostic tools, therapeutic innovations such as anti-vascular endothelial growth factor (VEGF) therapies, and supportive technologies to manage vision loss form the myopic macular degeneration market.

Better best-corrected visual acuity values and baseline thicker ganglion cell layer and retinal nerve fiber layer at ocular coherence tomography measurements were found to be the key predictive factors.

Catch up on the top stories in optometry during the week of July 28-August 1.

The latest in drug and technology developments and updates from July 2025.

Additionally, the company is exploring different strategic alternative to advance its suprachoroidal space (SCS) platform and drug development pipeline.

The solution was approved by the US Food and Drug Administration in late May 2025.

The new facility has opened just in time to see its first classes held in the fall semester.

The expanded clinical suite at Stanton Optical will include keratography, optical coherence tomography, and personalized therapy options for patients with dry eye.

The first-in-class, twice-daily topical formulation is intended for the treatment of nonproliferative diabetic retinopathy and diabetic macular edema.

A total of $7000 in scholarships was awarded to 3 optometry students as part of the National Optometric Student Association (NOSA) scholarship program.

The study's primary objective was to demonstrate that LUMIFY Preservative Free redness reliever eye drops are noninferior to LUMIFY redness reliever eye drops in reducing ocular redness.

The module can be used in combination with Ziemer’s FEMTO LDV Z8 femtosecond laser platform, an all-in-one laser for refractive, cataract, and therapeutic surgery.